Oliver Sartor, MD
C. E. and Bernadine Laborde Professor of Cancer Research
Medical Director, Tulane Cancer Center
Associate Dean for Oncology
Tulane University School of Medicine
New Orleans, LA
Oliver Sartor, MD, is the C. E. and Bernadine Laborde Professor of Cancer Research and medical director of the Tulane Cancer Center in New Orleans, LA. He currently serves as the associate dean for oncology at Tulane University School of Medicine and is a board member of the Louisiana Cancer Research Consortium, a legislatively established collaborative cancer research effort between Louisiana State University, Tulane University, Xavier University, and Ochsner Health System.
Dr Sartor’s clinical and research interests have focused broadly on prostate cancer over the years. He is involved in a wide variety of clinical trials covering both translational issues and advanced treatments. In some of these trials, he serves in national leadership positions. He has published more than 400 peer-reviewed manuscripts and has given hundreds of invited lectures on advanced prostate cancer in 33 countries during his career. He has been the principal investigator and co–principal investigator for 4 pivotal trials leading to US Food and Drug Administration approvals (samarium sm 153 lexidronam, cabazitaxel, leuprolide, and radium 223 dichloride). He serves widely as a consultant to biotechnology companies on matters pertaining to prostate cancer and drug development projects, particularly on matters pertaining to radiopharmaceuticals.